23 - 24 Mar 2021Ended

CRISPR In Drug Discovery


Estimated Turnout

100 - 500
Based on previous editions


Mar 2021
+1 more edition


Next edition likely in Apr 2021
Claim event to edit details

In accordance with current government guidelines on the COVID-19 pandemic, the third CRISPR in Drug Discovery: From Targets to Therapeutics meeting .. Read more will be held on 23rd and 24th March 2021 as a virtual event. Genome Engineering, including zinc-finger nucleases, TALENs and most recently CRISPR/Cas9, has become a powerful tool in the drug discovery pipeline. This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, developing advanced cellular and in vivo disease models for target validation, and the pioneering applications in therapeutic genome editing. A current perspective of the applications of these rapidly developing technologies with a focus on drug discovery applications will be the meeting’s focus. We aim to bring together the research community working in the field of genome engineering with interests in developing and applying the technology for pharmaceutical research. Join scientists from academia, pharma, biotech and CRO’s online to hear talks given by speakers at the cutting edge of genome engineering, network at the virtual exhibition and gain strategic insights into solutions for increasing the success of drug discovery and development. If you plan to attend an ELRIG event download the free ELRIG app and access all our conference information and lecture schedules and more straight from your phone or pad.

  • Followers
  • [ Users who have shown interest for this Event ]
Prof Raymond Hill

Prof Raymond Hill

Professor of Pharmacology at Imperial College London

London Borough of Wandsworth, United Kingdom


Undergraduate Student at Universidad Peruana Cayetano Heredia

Lima, Peru
  • Share your Experience
  • Organizer

More Events From The Organizer